Brief: Aquestive Therapeutics Inc Says Received Notice From Nasdaq Informing Co That It Has Regained Compliance With Nasdaq
13/04/2023 23:04
April 13 (Reuters) - Aquestive Therapeutics Inc
AQST.O :
* AQUESTIVE THERAPEUTICS INC - RECEIVED NOTICE FROM NASDAQ
INFORMING CO THAT IT HAS REGAINED COMPLIANCE WITH NASDAQ
Source text for Eikon: ID:
Further company coverage: AQST.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million